Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case report: pyruvate kinase deficiency

J M Rothman1

  • 1South Jersey Hospital System, Millville, USA.

New Jersey Medicine : the Journal of the Medical Society of New Jersey
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction.

Circulation·1998
Same author

Somatostatin along the auditory pathway.

Hearing research·1979
Same journal

Putting the public back in the public health.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Computer as consultants.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Epilepsy in pregnancy.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

New regulation for prescriptions.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Paradise lost: the high cost of infertility.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Julie Goldman. The New Jersey medicine interview. Interview by Bill Berlin.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
See all related articles

Pyruvate kinase deficiency, a rare cause of congenital hemolytic anemia, can be successfully treated with splenectomy. This procedure offered positive outcomes for two sisters diagnosed with the condition at birth.

Area of Science:

  • Biochemistry
  • Hematology
  • Genetics

Background:

  • Pyruvate kinase deficiency (PKD) is an inherited metabolic disorder.
  • It is a rare cause of congenital hemolytic anemia, characterized by premature destruction of red blood cells.
  • Nonspherocytic hemolytic anemia indicates red blood cells lack a normal spherical shape and have a shortened lifespan.

Observation:

  • Two sisters presented with profound jaundice and congenital nonspherocytic hemolytic anemia at birth.
  • Despite the rarity of reports on splenectomy for PKD, the procedure was considered for these siblings.
  • Splenectomy involves the surgical removal of the spleen, an organ that can be enlarged and overactive in hemolytic anemias.

Findings:

  • Splenectomy was performed on both siblings diagnosed with pyruvate kinase deficiency.

Related Experiment Videos

  • The surgical intervention resulted in successful clinical outcomes for both sisters.
  • This suggests splenectomy can be an effective treatment option for severe cases of PKD.

    • Implications:

    • The findings suggest that splenectomy should be considered in managing severe congenital nonspherocytic hemolytic anemia due to pyruvate kinase deficiency.
    • Further research into the long-term effects and optimal timing of splenectomy for PKD is warranted.
    • Successful splenectomy may improve the quality of life for patients with this rare genetic disorder.